Latest Expert Opinions

Signal
Opinion
Expert
SHORT
SHORT
November 13, 2020
They have a small short on it. Has decent price momentum but the valuation is still a challenge. Return on equity is negative at -12%, with a stressed balance sheet. Interest coverage looks poor. One that he would avoid.
Show full opinionHide full opinion
Maxar Technologies (MAXR-T)
November 13, 2020
They have a small short on it. Has decent price momentum but the valuation is still a challenge. Return on equity is negative at -12%, with a stressed balance sheet. Interest coverage looks poor. One that he would avoid.
COMMENT
COMMENT
November 13, 2020

The challenge with tech is that there are a couple different groups within the sector. There are very expensive beneficiaries of the pandemic, such as ZOOM, which are challenges. They do not have traditional valuation metrics. Other groups exist, like FANG and Microsoft. It is not the best value opportunity however.

Show full opinionHide full opinion

The challenge with tech is that there are a couple different groups within the sector. There are very expensive beneficiaries of the pandemic, such as ZOOM, which are challenges. They do not have traditional valuation metrics. Other groups exist, like FANG and Microsoft. It is not the best value opportunity however.

BUY
BUY
November 13, 2020
It has a strong price trend, and the valuation is still reasonable. The return on equity is very high quality at 42%. It does not look cheap on the PE basis with 33x or 34x earnings, but it has a great balance sheet, pays a yield with a low payout ratio, and they are buying back stocks. A cashflow machine.
Show full opinionHide full opinion
Microsoft (MSFT-Q)
November 13, 2020
It has a strong price trend, and the valuation is still reasonable. The return on equity is very high quality at 42%. It does not look cheap on the PE basis with 33x or 34x earnings, but it has a great balance sheet, pays a yield with a low payout ratio, and they are buying back stocks. A cashflow machine.
BUY WEAKNESS
BUY WEAKNESS
November 13, 2020
Likes it and holds it. It's been 3 months since he started a position. He would not sell it, and it scores in the top 10% on valuation metrics. High return at 23%, with 12x earnings. Balance sheet is fine and pays a good yield of 4.5% at reasonable payout ratio. It should do well in the recovery.
Show full opinionHide full opinion
Likes it and holds it. It's been 3 months since he started a position. He would not sell it, and it scores in the top 10% on valuation metrics. High return at 23%, with 12x earnings. Balance sheet is fine and pays a good yield of 4.5% at reasonable payout ratio. It should do well in the recovery.
DON'T BUY
DON'T BUY
November 13, 2020
Has a small short on it. It is defensive but it is not cheap for the cashflow it generates. The earnings are 14x EBITA and 1.7x book with 24x price to earning. The yield is healthy at 4.5% but the payout ratio is rising.
Show full opinionHide full opinion
Emera Inc (EMA-T)
November 13, 2020
Has a small short on it. It is defensive but it is not cheap for the cashflow it generates. The earnings are 14x EBITA and 1.7x book with 24x price to earning. The yield is healthy at 4.5% but the payout ratio is rising.
COMMENT
COMMENT
November 13, 2020

Would prefer TOU over VET. The challenge is the stressed balance sheet for these energy providers. VET has some of the worst price momentum, value, volatility and earnings profile in terms of current return on equity. They can move quickly if they look like they will survive. If you are looking for a huge amount of leverage and upside for a recovery, you could own VET but TOU is the more stable choice.

Show full opinionHide full opinion
Tourmaline Oil Corp (TOU-T)
November 13, 2020

Would prefer TOU over VET. The challenge is the stressed balance sheet for these energy providers. VET has some of the worst price momentum, value, volatility and earnings profile in terms of current return on equity. They can move quickly if they look like they will survive. If you are looking for a huge amount of leverage and upside for a recovery, you could own VET but TOU is the more stable choice.

COMMENT
COMMENT
November 13, 2020

Would prefer TOU over VET. The challenge is the stressed balance sheet for these energy providers. VET has some of the worst price momentum, value, volatility and earnings profile in terms of current return on equity. They can move quickly if they look like they will survive. If you are looking for a huge amount of leverage and upside for a recovery, you could own VET but TOU is the more stable choice.

Show full opinionHide full opinion

Would prefer TOU over VET. The challenge is the stressed balance sheet for these energy providers. VET has some of the worst price momentum, value, volatility and earnings profile in terms of current return on equity. They can move quickly if they look like they will survive. If you are looking for a huge amount of leverage and upside for a recovery, you could own VET but TOU is the more stable choice.